Agilent Technologies, Inc.
General ticker "A" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $36.0B (TTM average)
Agilent Technologies, Inc. follows the US Stock Market performance with the rate: 69.0%.
Estimated limits based on current volatility of 1.1%: low 131.14$, high 134.11$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-01-06, amount 0.26$ (Y0.78%)
- Total employees count: 17900 (-1.1%) as of 2024
- China accounted for 18.7% of revenue in the fiscal year ended 2024-10-31
- US accounted for 34.5% of revenue in the fiscal year ended 2024-10-31
- Top business risk factors: Economic downturns and volatility, Currency fluctuations, Supply chain disruptions, Regulatory and compliance, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-10-31 to 2027-10-31
- 2025-10-31 to 2026-10-31 estimated range: [130.26$, 176.18$]
- 2026-10-31 to 2027-10-31 estimated range: [139.87$, 188.17$]
Financial Metrics affecting the A estimates:
- Positive: with PPE of 26.1 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 21.29 > 18.34
- Positive: Industry inventory ratio change (median), % of -0.80 <= -0.18
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.97 <= -0.75
- Positive: Interest expense per share per price, % of 0.27 <= 0.73
Short-term A quotes
Relationship graph
Long-term A plot with estimates
Financial data
| YTD | 2023-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|
| Operating Revenue | $6,833.00MM | $6,510.00MM | $6,948.00MM |
| Operating Expenses | $5,483.00MM | $5,022.00MM | $5,469.00MM |
| Operating Income | $1,350.00MM | $1,488.00MM | $1,479.00MM |
| Non-Operating Income | $-11.00MM | $33.00MM | $-44.00MM |
| Interest Expense | $95.00MM | $96.00MM | $112.00MM |
| R&D Expense | $481.00MM | $479.00MM | $455.00MM |
| Income(Loss) | $1,339.00MM | $1,521.00MM | $1,435.00MM |
| Taxes | $99.00MM | $232.00MM | $132.00MM |
| Profit(Loss)* | $1,240.00MM | $1,289.00MM | $2,172.00MM |
| Stockholders Equity | $5,845.00MM | $5,898.00MM | $6,741.00MM |
| Inventory | $1,031.00MM | $991.00MM | $1,025.00MM |
| Assets | $10,763.00MM | $11,846.00MM | $12,727.00MM |
| Operating Cash Flow | $1,772.00MM | $1,751.00MM | $1,559.00MM |
| Capital expenditure | $298.00MM | $378.00MM | $407.00MM |
| Investing Cash Flow | $-310.00MM | $-1,258.00MM | $-394.00MM |
| Financing Cash Flow | $-930.00MM | $-752.00MM | $-715.00MM |
| Earnings Per Share** | $4.22 | $4.44 | $7.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.